Contribution of the glycine site of NMDA receptors in rostral and intermediate-caudal parts of the striatum to the regulation of muscle tone in rats

Brain Research

Volumn 793, Issue 1-2, 1998, Pages 315-320

  Lorenc Koci, Elzbieta ^a   Konieczny, Jolanta ^a   Wolfarth, Stanisław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5,7 DCKA; MDA receptor glycine site; Muscle rigidity; Striatum

Indexed keywords

5,7 DICHLOROKYNURENIC ACID; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG MECHANISM; ELECTROMYOGRAM; GASTROCNEMIUS MUSCLE; MUSCLE RIGIDITY; MUSCLE TONE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; BINDING SITES; CORPUS STRIATUM; ELECTROMYOGRAPHY; GLYCINE; MALE; MUSCLE TONUS; MUSCLE, SKELETAL; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032543150     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00240-6     Document Type: Article

References (25)

1. M. Brenner, A. Haass, P. Jacobi, K. Schimrigk, Amantadine sulphate in treating Parkinson's disease: clinical effects, psychometric tests and serum concentrations, J. Neurol. 236 (3) (1989) 153-156.
2. C.B. Carroll, V. Holloway, J.M. Brotchie, I.J. Mitchell, Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms, Psychopharmacology 119 (1995) 55-65.
3. H. Ehringer, O. Hornykiewicz, Verteilung von noradrenalin und dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems, Klin. Wochenschr. 38 (1960) 1236-1239.
4. F. Fonnum, Glutamate: a neurotransmitter in mammalian brain, J. Neurochem. 42 (1984) 1-11.
5. C.R. Gerfen, The neostriatal mosaic: multiple levels of compartmental organization, Trends Neurosci. 15 (1992) 133-139.
6. O. Hornykiewicz, S.J. Kish, Biochemical pathophysiology of Parkinson's disease, Adv. Neurol. 45 (1986) 19-34.
7. J.A. Kemp, P.D. Leeson, The glycine site of the NMDA receptor -five years on, TiPS 14 (1993) 20-25.
8. T. Klockgether, L. Turski, NMDA antagonist potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats, Ann. Neurol. 28 (1990) 539-546.
9. B.D. Kretschmer, W.J. Schmidt, Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens, J. Neurosci. 16 (1996) 1561-1569.
10. B.D. Kretschmer, M. Bubser, W.J. Schmidt, Behavioral and neurochemical actions of the strychnine-insensitive glycine receptor antagonist, 7-chlorokynurenate, in rats, Eur. J. Pharmacol. 280 (1995) 37-45.
11. B.D. Kretschmer, B. Winterscheid, W. Danysz, W.J. Schmidt, Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats, J. Neural. Transm. Gen. Sect. 95 (1994) 123-136.
12. J.F.R. König, R.A., Klippel, The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem, Williams and Wilkins, Baltimore, 1963.
13. G.B. Landwehrmeyer, D.G. Standaert, C.M. Testa, J.B. Penney, A.B. Young, NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum, J. Neurosci. 15 (1995) 5297-5307.
14. E. Lorenc-Koci, S. Wolfarth, K. Ossowska, Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity, Exp. Brain Res. 109 (1996) 268-276.
15. K. Ossowska, The role of excitatory amino acids in experimental models of Parkinson's disease, J. Neural. Transm. Parkinson's Dis. Dementia Sect. 8 (1994) 39-71.
16. K. Ossowska, J. Konieczny, NMDA receptors in the rostral and intermediate-caudal striatum play an opposite role in regulation of the muscle tone in rats, Pol. J. Pharmacol. 48 (1996) 261-267.
17. K. Ossowska, E. Lorenc-Koci, S. Wolfarth, Antiparkinsonian action of (MK-801) on the reserpine-induced rigidity: a mechanomyographic analysis, J. Neural Transm. Parkinson's Dis. Dementia Sect. 7 (1994) 143-152.
18. K. Ossowska, E. Lorenc-Koci, G. Schulze, J. Konieczny, S. Wolfarth, M. Bojarski, H. Coper, The role of reflex activity in the regulation of muscle tone in rats, Exp. Physiol. 81 (1996) 211-223.
19. K. Ossowska, E. Lorenc-Koci, G. Schulze, S. Wolfarth, The influence of dizocilpine (MK-801) on the reserpine-enhanced electromyographic stretch reflex in rats, Neurosci. Lett. 203 (1996) 73-76.
20. J.M. Rabey, P. Nissipeanu, A.D. Korczyn, Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease, J. Neural. Transm. Parkinson's Dis. Dementia Sect. 4 (1992) 277-282.
21. P. Riederer, K.W. Lange, J. Kornhuber, W. Danielczyk, Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia, Arzneim.-Forsch./Drug Res. 42 (I) (1992) 265-268.
22. W.J. Schmidt, B.D. Kretschmer, Behavioural pharmacology of glutamate receptors in the basal ganglia, Neurosci. Biobehav. Rev. 4 (1997) 381-392.
23. S.J. Tallaksen-Greene, R.G. Wiley, R.L. Albin, Localization of striatal excitatory amino acid binding site subtypes to strionigral projection neurons, Brain Res. 594 (1992) 167-170.
24. Y. Yoshida, T. Ono, A. Kizu, R. Fukushima, T. Miyagishi, Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy, Eur. J. Pharmacol. 203 (1991) 173-180.
25. Y. Yoshida, T. Ono, K. Kawano, T. Miyagishi, Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen, Brain Res. 639 (1994) 139-148.